These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21270413)

  • 1. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine.
    Manack A; Buse DC; Serrano D; Turkel CC; Lipton RB
    Neurology; 2011 Feb; 76(8):711-8. PubMed ID: 21270413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache disability among adolescents: a student population-based study.
    Fuh JL; Wang SJ; Lu SR; Liao YC; Chen SP; Yang CY
    Headache; 2010 Feb; 50(2):210-8. PubMed ID: 19804389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Migraine: clinical features and disability in a rural population in Cuba].
    Quesada-Vazquez AJ; Contreras-Maure LJ; Traba-Tamayo ER; Frometa-Guerra A
    Rev Neurol; 2010 Jan 16-31; 50(2):72-6. PubMed ID: 20112214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.
    Dahlöf CG; Johansson M; Casserstedt S; Motallebzadeh T
    Headache; 2009 Sep; 49(8):1144-52. PubMed ID: 19719542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine in Assiut Governorate, Egypt: epidemiology, risk factors, comorbid conditions and predictors of change from episodic to chronic migraine.
    Kandil MR; Hamed SA; Fadel KA; Khalifa HE; Ghanem MK; Mohamed KO
    Neurol Res; 2016 Mar; 38(3):232-41. PubMed ID: 27078706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIDAS and HIT-6 French translation: reliability and correlation between tests.
    Magnoux E; Freeman MA; Zlotnik G
    Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of migraine and tension-type headache: a population-based follow-up study.
    Lyngberg AC; Rasmussen BK; Jørgensen T; Jensen R
    Neurology; 2005 Aug; 65(4):580-5. PubMed ID: 16116119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Manack AN; Reed ML; Buse DC; Varon SF; Lipton RB
    Value Health; 2013; 16(1):31-8. PubMed ID: 23337213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
    Tepper SJ; Dahlöf CG; Dowson A; Newman L; Mansbach H; Jones M; Pham B; Webster C; Salonen R
    Headache; 2004 Oct; 44(9):856-64. PubMed ID: 15447694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
    D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
    Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache and symptoms of temporomandibular disorder: an epidemiological study.
    Gonçalves DA; Bigal ME; Jales LC; Camparis CM; Speciali JG
    Headache; 2010 Feb; 50(2):231-41. PubMed ID: 19751369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field testing alternative criteria for chronic migraine.
    Bigal ME; Tepper SJ; Sheftell FD; Rapoport AM; Lipton RB
    Cephalalgia; 2006 Apr; 26(4):477-82. PubMed ID: 16556250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine days decline with duration of illness in adolescents with transformed migraine.
    Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
    Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
    Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
    Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
    Masruha MR; Lin J; de Souza Vieira DS; Minett TS; Cipolla-Neto J; Zukerman E; Vilanova LC; Peres MF
    Headache; 2010 Mar; 50(3):413-9. PubMed ID: 19817880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute treatment of episodic and chronic migraine in the USA.
    Bigal ME; Borucho S; Serrano D; Lipton RB
    Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.